A comparative study of concurrent chemoradiotherapy with cisplatin versus nedaplatin for patients with middle-advanced stage uterine cervical cancer

Tumor

Volumn 31, Issue 7, 2011, Pages 662-664

  Cheng, Xiao Wei ^a   Yang, Yu Xing ^a   Yu, Xiao Yuan ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Cisplatin; Concurrent chemoradiotherapy; Nedaplatin; Uterine cervical neoplasms

Indexed keywords

CISPLATIN; NEDAPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISTANT METASTASIS; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; THROMBOCYTOPENIA; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

EID: 79961116714     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2011.07.017     Document Type: Article

References (7)

1. EIFEL P J, WINTER K, MORRIS M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aoritc irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01[J]. J Clin Oncol, 2004, 22(5): 872-880.
2. GREEN J A, KIRWAN J W, TIEMEY J F, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic and metaanalysis[J]. Lancet, 2001, 358(9): 781-786.
3. YAMADA H, UCHIDA N, MAEKAWA R, et al. Sequence dependent antitumor efficacy of combination chemotherapy with nedaplatin, a newly developed platinum, and palitaxel[J]. Cancer Lett, 2001, 172(1): 17-25.
4. SHIRAI T, HIROSE T, NODA M, et al. Phase II study of the combination of gemcitabine and nedaplatin for advanced non-small-cell lung cancer[J]. Lung Cancer, 2006, 52(2): 181-187.